"At UCSF Health, we're taking every precaution to keep you safe and healthy during the COVID-19 pandemic. For our outpatients, we offer video visits and virtual care for hundreds of conditions as well as for primary care, mental health services, medication monitoring and more. In our hospitals, we test every patient admitted and before most procedures. Our staff wears face masks and practices rigorous hand hygiene, as well as many other methods of infection prevention. Before entering your room, they'll make sure you're masked and (in UCSF Benioff Children's Hospitals) that your child age 2+ is masked. If you're planning to visit someone in the hospital, be sure to check our COVID-19 visitor restrictions before going."

During the past decade, UCSF Memory and Aging Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 6 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSF Memory and Aging Center" #1 sponsor was "University of California, San Francisco" with 6 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Biogen" with 2 trials sponsored, "TauRx Therapeutics Ltd" with 2 trials sponsored and "Alector Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSF Memory and Aging Center" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Harvard School of Public Health (HSPH)" with 1 trials as a collaborator and "National Institute of Nursing Research (NINR)" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "UCSF Memory and Aging Center" are "Alzheimer's Disease" (8 trials), "Alzheimer Disease" (3 trials), "Multiple System Atrophy" (2 trials), "Anxiety" (1 trials) and "Awe" (1 trials). Many other conditions were trialed in "UCSF Memory and Aging Center" in a lesser frequency.

Most popular intervention types in "UCSF Memory and Aging Center" are "Drug" (19 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Crenezumab" (3 trials), "Verdiperstat" (2 trials), "AL002" (1 trials) and "Aducanumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCSF Memory and Aging Center" are 23 trials for "All" genders.

Currently, there are NaN active trials in "UCSF Memory and Aging Center". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in UCSF Memory and Aging Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in UCSF Memory and Aging Center, 6 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".